Latest News

26 April 2019

Subscription of 36,363,636 new Ordinary Shares at a price of 1.1 pence per share to raise gross proceeds of £400,000 Proposed Approval of Waiver of the obligations under Rule 9 of the Takeover Code and Notice of General Meeting

14 March 2019

OKYO releases preclinical data on OKYO-0101 at the 14th Congress on Ocular Pharmacology and Therapeutics, 2019 demonstrating its potential to treat dry eye.

07 March 2019

Presentation of Preclinical Data Demonstrating Potential of OKYO-0101 for Dry Eye Treatment

23 January 2019

OKYO Pharma Corporate Update

30 November 2018

Interim results for the six months to 30 September 2018

01 November 2018

Expected Admission Date for Consideration Shares

Page 2 of 3 Previous Next